• Mycoplasma genitalia – a mysterious destroyer
To content

Mycoplasma genitalia – a mysterious destroyer

HEALTH OF WOMAN. 2018.5(132):10–14; doi 10.15574/HW.2018.132.10

Burka O. A., Ligirda N. F.
ML DEAL
Bogomolets National Medical University, Kiev
National Cancer Institute, Kyiv

Mycoplasma genitalium is a common cause of cervicitis and non-gonococcal urethritis. Today, this causative agent is already associated with inflammatory diseases of the pelvic organs and sexually acquired reactive arthritis. The only diagnostic method is a nucleic acid amplification (NAAT) test that detects specific DNA (PCR) or M. genitalium RNA. Several treatment regimens are proposed, depending on the uncomplicated or complicated course of M. genitalium infection and the determination of macrolide resistance.

Key words: Mycoplasma genitalium, sexually transmitted infections, inflammatory diseases of the pelvic organs, cervicitis, non-gonococcal urethritis.

REFERENCES

1. WHO, GLOBAL HEALTH SECTOR STRATEGY ON SEXUALLY TRANSMITTED INFECTIONS 2016–2021.

2. WHO. Laboratory diagnosis of sxually transmitted infections, including human immunodeficiency virus. 2013.

3. Lis R, Rowhani-Rahbar A, Manhart LE. 2015. Mycoplasma genitalium infection and female reproductive trat disease: a meta-analysis. Clin Infect Dis. 61(3):418-426. https://doi.org/10.1093/cid/civ312; PMid:25900174

4. Sonnenberg P et al. 2015. Epidemiology of Mycoplasma genitalium in British men and women aged 16-44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int J Epidemiol. 44(6):1982-94. https://doi.org/10.1093/ije/dyv194; PMid:26534946 PMCid:PMC4690003

5. 2018 BASHH UK national guideline for the management of infection with Mycoplasma genitalium. Draft.

6. By Litty Tan, BSc, Phd. 2017. Clinical and diagnostic challenges of antimicrobial resistance in Mycoplasma genitalium. 49;5.

7. 2016 European guideline on Mycoplasma genitalium infections Sexually Transmitted Diseases Treatment Guidelines. 2015.